Inflammatory pathways in alcoholic steatohepatitis

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Bin Gao, Hidekazu Tsukamoto  Gastroenterology 
Pathological roles of purinergic signaling in the liver
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
Pathways of liver injury in alcoholic liver disease
The inflammasome in liver disease
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Gianluca Tell, Carlo Vascotto, Claudio Tiribelli  Journal of Hepatology 
Thoetchai (Bee) Peeraphatdit, Douglas A. Simonetto, Vijay H. Shah 
Alcohol and toxicity Journal of Hepatology
The gut microbiota and the liver
Living donor liver transplantation: is the hype over?
Gut–liver immunity Journal of Hepatology
Mesenchymal stromal cell therapy for liver diseases
Arun J. Sanyal, Veronica Miller  Gastroenterology 
Volume 69, Issue 2, Pages (August 2018)
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Targeting the gut-liver axis in liver disease
Inflammation and portal hypertension – The undiscovered country
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
Targeting gut flora to prevent progression of hepatocellular carcinoma
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Volume 62, Issue 3, Pages (March 2015)
Autophagy in the liver Journal of Hepatology
Volume 59, Issue 3, Pages (September 2013)
Pathways of liver injury in alcoholic liver disease
The Cellular and Molecular Basis of Translational Immunometabolism
The Origins and Drivers of Insulin Resistance
Gut-Pancreatic Axis AMPlified in Islets of Langerhans
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Bridging immunity and lipid metabolism by gut microbiota
An Integrated View of Immunometabolism
Cannabinoid signaling and liver therapeutics
Volume 63, Issue 2, Pages (August 2015)
Karel J. van Erpecum, Frank G. Schaap  Journal of Hepatology 
The Cellular and Molecular Basis of Translational Immunometabolism
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
NASH animal models: Are we there yet?
Homeostasis and Inflammation in the Intestine
miR-122 – A key factor and therapeutic target in liver disease
Subhra K. Biswas, Raffaella Bonecchi  Cell Metabolism 
Global burden of alcoholic liver diseases
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
The dynamic biliary epithelia: Molecules, pathways, and disease
The use of hemospray in portal hypertensive bleeding; a case series
Pathogenesis of cholestatic hepatitis C
Risk factors and mechanisms of non-alcoholic steatohepatitis
The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?  Mario Strazzabosco, Luca Fabris 
Chimeric mouse model of hepatitis B virus infection
Cytokines and the immunomodulatory function of the vagus nerve
Microbiome as a therapeutic target in alcohol-related liver disease
Volume 58, Issue 4, Pages (April 2013)
Nathalie Ganne-Carrié, Pierre Nahon  Journal of Hepatology 
Shih-Yen Weng, Detlef Schuppan  Journal of Hepatology 
Platelets arrive at the scene of fibrosis……studies
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Presentation transcript:

Inflammatory pathways in alcoholic steatohepatitis Bin Gao, Maleeha F. Ahmad, Laura E. Nagy, Hidekazu Tsukamoto  Journal of Hepatology  Volume 70, Issue 2, Pages 249-259 (February 2019) DOI: 10.1016/j.jhep.2018.10.023 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Inter-organ crosstalk contributes to the progression of ALD. Inter-organ crosstalk contributes to inflammation, metabolic alternations, and cell death in ALD. The gut-liver axis involves enteric dysbiosis, a loss of barrier function leading to translocation of microbes and microbial products to the portal circulation. Loss of bile acid homeostasis also contributes to liver injury. Adipose tissue is an important organ in integrating metabolism and immunity; ethanol impacts both the metabolic and immune functions of adipose tissue. Sympathetic innervation to the liver via the vagus nerve can also regulate inflammatory responses. Organ-organ crosstalk is mediated by the release of mediators, including neurotransmitters, cytokines, chemokines, adipokines, miRNAs and metabolites. These mediators can either be present in the circulation and/or carrier in extracellular vesicles. ALD, alcohol-related liver disease. Journal of Hepatology 2019 70, 249-259DOI: (10.1016/j.jhep.2018.10.023) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions